AGGREGATED External reporting by CNBC. This page summarizes the publisher's feed entry; the full article is on www.cnbc.com.
Moderna raises 2026 outlook as CEO says newer vaccines are gaining traction
The biotech company now expects 2026 revenue growth of 15% to 25%, up from its previous guidance of up to 10%.